2023
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada
Bahji A, Hathaway J, Adams D, Crockford D, Edelman E, Stein M, Patten S. Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada. Addiction 2023, 119: 137-148. PMID: 37766508, DOI: 10.1111/add.16337.Peer-Reviewed Original ResearchConceptsCVD eventsRisk ratioIncident CVDPopulation-based retrospective cohort analysisPopulation-based retrospective cohort studyAdverse cardiovascular disease (CVD) eventsAdverse cardiovascular disease outcomesAdverse CVD eventsGreater risk ratioIncident CVD eventsRetrospective cohort studyAdverse cardiovascular outcomesCardiovascular disease eventsRetrospective cohort analysisCardiovascular disease outcomesMental health comorbiditiesTime of presentationAdministrative health databasesHealth service usePrescription medication useCannabis use disorderMantel-Haenszel techniqueHealth care servicesPoisson regression modelsYear of birth
2022
The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study
Morford K, Tetrault J, Zhou B, Li F, Gleeson B, Edelman E, Stein M, Barry D, Madden L. The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study. Drug And Alcohol Dependence 2022, 241: 109707. PMID: 36423462, PMCID: PMC9777057, DOI: 10.1016/j.drugalcdep.2022.109707.Peer-Reviewed Original ResearchConceptsBenzodiazepine exposureRetrospective cohort studyKaplan-Meier analysisTreatment retentionCohort studyCox regressionTreatment durationMedian treatment durationMultivariable Cox regressionCohort of patientsOpioid treatment programsOpioid use disorderLog-rank testSame-day accessDrug Administration recommendationsTreatment discontinuationUrine toxicologyMeier analysisMethadone programsUse disordersPatientsAdministration recommendationsTreatment entryTreatment programTreatment barriers